Filing Details
- Accession Number:
- 0001213900-18-011407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-20 10:26:37
- Reporting Period:
- 2018-08-16
- Accepted Time:
- 2018-08-20 10:26:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384044 | Scott David Tomsche | C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.10 Per Share | Acquisiton | 2018-08-16 | 3,000 | $6.67 | 75,789 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- (1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.
Billionaire Hedge Funds
